Amorphex Therapeutics develops a platform technology for ocular drug delivery.
Amorphex Therapeutics has raised $265K in total funding. The most recent round was Seed. The last funding was announced in January 2023.
Amorphex Therapeutics is headquartered in Andover, United States.
Amorphex Therapeutics develops a platform technology for ocular drug delivery.
Amorphex Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amorphex Therapeutics — Funding & Investors." VCBacked, January 20, 2023, https://www.vcbacked.co/company/amorphex-therapeutics. Accessed August 16, 2026.
VCBacked. (2023). Amorphex Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/amorphex-therapeutics
{{cite web |title=Amorphex Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amorphex-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated